<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Orbital radiotherapy for adult thyroid eye disease - Rajendram, R - 2012 | Cochrane Library</title> <meta content="Orbital radiotherapy for adult thyroid eye disease - Rajendram, R - 2012 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007114.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Orbital radiotherapy for adult thyroid eye disease - Rajendram, R - 2012 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007114.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007114.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Orbital radiotherapy for adult thyroid eye disease" name="citation_title"/> <meta content="Rathie Rajendram" name="citation_author"/> <meta content="Moorfields Eye Hospital NHS Foundation Trust" name="citation_author_institution"/> <meta content="rathie.rajendram@moorfields.nhs.uk" name="citation_author_email"/> <meta content="Catey Bunce" name="citation_author"/> <meta content="Moorfields Eye Hospital NHS Foundation Trust" name="citation_author_institution"/> <meta content="Richard WJ Lee" name="citation_author"/> <meta content="Ana MS Morley" name="citation_author"/> <meta content="St. Thomas's Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD007114.pub2" name="citation_doi"/> <meta content="2012" name="citation_date"/> <meta content="2012/07/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007114.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007114.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007114.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Inflammatory Agents [therapeutic use]; Graves Ophthalmopathy [drug therapy, *radiotherapy]; Methylprednisolone [therapeutic use]; Prednisolone [therapeutic use]; Quality of Life; Randomized Controlled Trials as Topic; Steroids [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007114.pub2&amp;doi=10.1002/14651858.CD007114.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007114\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007114\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr"],languageCode:"en",accessStatus:"none",doi:"10.1002/14651858.CD007114.pub2",title:"Orbital radiotherapy for adult thyroid eye disease",firstPublishedDate:"Jul 11, 2012 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007114.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007114.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007114.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007114.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007114.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007114.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007114.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007114.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007114.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007114.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>784 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007114.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-sec1-0005"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/appendices#CD007114-sec1-0011"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/table_n/CD007114StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/table_n/CD007114StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2012 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Orbital radiotherapy for adult thyroid eye disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information#CD007114-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Rathie Rajendram</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information#CD007114-cr-0003">Catey Bunce</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information#CD007114-cr-0004">Richard WJ Lee</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information#CD007114-cr-0005">Ana MS Morley</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information/en#CD007114-sec1-0013">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 July 2012 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007114.pub2">https://doi.org/10.1002/14651858.CD007114.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007114-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007114-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007114-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007114-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007114-abs-0001" lang="en"> <section id="CD007114-abs1-0001"> <h3 class="title" id="CD007114-abs1-0001">Background</h3> <p>Thyroid eye disease is an autoimmune inflammatory condition of the orbital and periorbital tissues. Orbital radiotherapy is an anti‐inflammatory treatment used in the treatment of active thyroid eye disease. It is administered as an outpatient procedure in 10 to 12 fractionated doses. </p> </section> <section id="CD007114-abs1-0002"> <h3 class="title" id="CD007114-abs1-0002">Objectives</h3> <p>To assess the effectiveness and adverse events of orbital radiotherapy in thyroid eye disease. The effectiveness was dependent on the level of 'success' of the intervention predefined in each randomised controlled trial (RCT). </p> </section> <section id="CD007114-abs1-0003"> <h3 class="title" id="CD007114-abs1-0003">Search methods</h3> <p>We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (<i>The Cochrane Library</i> 2012, Issue 2), MEDLINE (January 1950 to March 2012), EMBASE (January 1980 to March 2012), Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to March 2012), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not restrict the electronic searches for trials by date or language. We last searched the electronic databases on 12 March 2012. We screened reference lists of reports of included studies, other reviews and book chapters to find additional trials. We contacted trial investigators and experts in the field to identify additionally published studies. </p> </section> <section id="CD007114-abs1-0004"> <h3 class="title" id="CD007114-abs1-0004">Selection criteria</h3> <p>We included RCTs of orbital radiotherapy versus sham radiotherapy or other interventions enrolling adults, with a minimum of three months' follow‐up and an endpoint of two years or less post treatment. </p> </section> <section id="CD007114-abs1-0005"> <h3 class="title" id="CD007114-abs1-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trial quality and extracted data. Trial authors were contacted for missing data. The risk ratio was used for our primary outcome. For our secondary outcomes, the odds ratio and mean difference were reported where possible. </p> </section> <section id="CD007114-abs1-0006"> <h3 class="title" id="CD007114-abs1-0006">Main results</h3> <p>We obtained full‐text copies of nine potential studies and included five trials with a total of 244 participants in this review. Orbital radiotherapy was compared to sham radiotherapy in two studies and to glucocorticoids in three studies, as a monotherapy or combination therapy. There was heterogeneity (as defined in our protocol) of trial outcome measures. Our primary outcome of a composite score was used in the two trials comparing radiotherapy versus sham radiotherapy and showed a risk ratio of success of 1.92 (95% confidence interval (CI) 1.27 to 2.91) in favour of orbital radiotherapy. The primary outcome was not used in the other three trials. </p> </section> <section id="CD007114-abs1-0007"> <h3 class="title" id="CD007114-abs1-0007">Authors' conclusions</h3> <p>This review found that orbital radiotherapy is more effective than sham radiotherapy for the treatment of mild‐to‐moderate thyroid eye disease. In a single trial no difference between radiotherapy and steroid monotherapy was found. A meta‐analysis of our secondary outcome of disease severity was not possible but results from individual trials suggest a better outcome with combination treatment with steroids versus steroids alone. No significant changes in quality‐of‐life scores following treatment with radiotherapy versus alternative treatments were found. Short‐term adverse events related to radiotherapy that were reported were local and mild but long‐term data were lacking and development of retinal changes following radiotherapy was not reported on. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007114-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007114-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007114-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007114-abs-0005">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007114-abs-0004" lang="en"> <h3>Orbital therapy for adult thyroid eye disease</h3> <p>Thyroid eye disease is a condition that is still not fully understood but results in inflammation of the eye and the tissues around the eye. It can cause changes in appearance (such as puffiness and redness of eyelids and conjunctiva, 'starey' eyes and misaligned eyes), discomfort, double vision and decreased vision. Orbital radiotherapy is a treatment given to reduce the inflammation and its associated changes. It is given in an outpatient setting and as the dose is divided into smaller daily doses it often involves up to 12 visits. This review included five randomised controlled trials involving 244 participants. A combined analysis of trials using our primary outcome showed that the 'risk' of success in a patient who received radiotherapy was 1.92 times that of a patient who did not receive radiotherapy. Single studies suggested that orbital radiotherapy in combination with steroids had a better outcome than steroids alone. There was no significant change in quality‐of‐life information collected in the orbital radiotherapy groups compared to the other groups. The short‐term adverse events reported in the trials were mild and localised to the area of treatment (redness of skin and temporal hair loss). However, trial methodology may have led to a decreased rate of adverse events from radiotherapy. Three trials excluded diabetic patients and these patients have been reported, in the literature, to be at higher risk of developing radiation retinopathy and of having progression of pre‐existing diabetic retinopathy. Some studies did not report on retinal changes at all. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007114-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007114-sec1-0006"></div> <h3 class="title" id="CD007114-sec1-0007">Implications for practice</h3> <section id="CD007114-sec1-0007"> <p>This small systematic review would support the use of orbital radiotherapy as monotherapy for moderate TED in current practice. As a meta‐analysis of orbital radiotherapy combined with steroids versus steroids alone could not be carried out this review cannot comment on its use as a combination therapy, even though single studies favoured dual therapy. The studies did not include severe TED and therefore the review cannot recommend whether radiotherapy should be used in these patients or not. The cost effectiveness of radiotherapy in TED cannot be discussed as the cost was only assessed in one study from one country in the context of mild TED and found a 12% increase in cost compared to sham. Further studies investigating cost effectiveness in regard to moderate, as well as mild disease, and comparison to other interventions are needed before this can be taken into account. </p> </section> <h3 class="title" id="CD007114-sec1-0008">Implications for research</h3> <section id="CD007114-sec1-0008"> <p>The review has significant implications for research as it highlights the variation in inclusion criteria, outcome measures and study design currently used in trials assessing treatments for TED. This range reflects the subjective nature of much of the condition and the lack of obvious objective outcome measures. It also reflects the variable natural history of the disease and presentations. However, future research into this area must try and use more universal inclusion criteria, parallel study designs and reproducible outcome measures, which will permit meta‐analysis of studies to be undertaken. Specific areas of research include the impact of the disease and treatments on patients' quality of life as well as health economics. The use of radiotherapy in severe TED has not been explored but enrolling patients with significant sight‐threatening pathology that could become permanent would have ethical issues. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007114-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007114-sec1-0001"></div> <section id="CD007114-sec2-0001"> <h3 class="title" id="CD007114-sec2-0001">Description of the condition</h3> <p>Thyroid eye disease (TED) affects 25% to 50% of patients with Graves' disease (<a href="./references#CD007114-bbs2-0010" title="BahnRS , HeufelderAE . Pathogenesis of Graves' ophthalmopathy. New England Journal of Medicine1993;329(20):1468‐75. ">Bahn 1993</a>), which is approximately 400,000 people in the UK (<a href="./references#CD007114-bbs2-0016" title="CawoodT , MoriartyP , O'SheaD . Recent developments in thyroid eye disease. BMJ2004;329(7462):385‐90. ">Cawood 2004</a>). Clinically, it is characterised by an aching sensation behind the eyes, swelling and redness of the eyelids and conjunctiva, protrusion of the eyes (proptosis) and double vision. In a small minority (6%) of patients vision is also threatened by compression of the optic nerve (<a href="./references#CD007114-bbs2-0012" title="BartalenaL , PincheraA , MarcocciC . Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews2000;21(2):168‐99. ">Bartalena 2000</a>). TED is therefore a visually disabling and cosmetically disfiguring condition that significantly impairs quality of life (<a href="./references#CD007114-bbs2-0049" title="TerweeC , WakelkampI , TanS , DekkerF , PrummelMF , WiersingaW . Long‐term effects of Graves' ophthalmopathy on health‐related quality of life. European Journal of Endocrinology2002;146(6):751‐7. ">Terwee 2002</a>). </p> <p>The cellular and molecular basis remains incompletely understood and it has long been postulated that the common link between Graves' disease and TED is a misdirected immune response targeting the thyroid‐stimulating hormone receptor (TSHr), although insulin‐like growth factor receptor 1 (IGFR1) has also been shown to play a role (<a href="./references#CD007114-bbs2-0044" title="SmithTJ . The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin‐like growth factor‐1 receptor in fibroblast activation. Autoimmunity2003;36:409‐15. ">Smith 2003</a>). There is an increasing amount of basic research being carried out on TED and the intricacies of disease mechanism are continuing to unfold. We will provide a simplified summary for the purpose of this systematic review. B cells and T cells, which are part of the body's immune system, respond to an autoimmune signal and migrate to the orbit. This signal is presumably multifactorial and is likely to be due to both environmental and genetic risk factors (<a href="./references#CD007114-bbs2-0046" title="StanMN , BahnRS . Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid2010;20(7):777‐83. ">Stan 2010</a>). It results in T‐cell driven inflammation and B cells are also stimulated to produce autoantibodies against the TSHr and IGFR1 (<a href="./references#CD007114-bbs2-0027" title="LehmannGM , FeldonSE , SmithTJ , PhippsRP . Immune mechanisms in thyroid eye disease. Thyroid2007;18(9):959‐65. ">Lehmann 2007</a>), which are expressed on orbital fibroblasts (<a href="./references#CD007114-bbs2-0011" title="BahnRS . Graves' ophthalmopathy. New England Journal of Medicine2010;362(8):726‐38. ">Bahn 2010</a>). The result is the release of further cytokines and chemokines that perpetuate the proinflammatory immune response. Fibroblasts also secrete glycosaminoglycans (<a href="./references#CD007114-bbs2-0045" title="SmithTJ , HoaN . Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self‐antigen, insulin‐like growth factor‐I receptor. Journal of Clinical Endocrinology and Metabolism2004;89(10):5076‐80. ">Smith 2004</a>), which as well as being hydrophilic, have subclasses that can differentiate into myofibrocytes (muscle fibre precursors) and adipocytes (fat cells) (<a href="./references#CD007114-bbs2-0050" title="VanSteenselL , DikWA . The orbital fibroblast: a key player and target for therapy in Graves' ophthalmopathy. Orbit2010;29(4):202‐6. ">Van Steensel 2010</a>). Clinically, these changes are manifest as extraocular muscle enlargement and an increase in the volume of orbital fat, which is readily demonstrated on magnetic resonance imaging (MRI) and computed tomography (CT) scans. The globe is pushed forwards, if the surrounding anatomy allows it to be, which is seen as proptosis. If the globe is prevented from this 'self decompression' a vicious cycle of orbital congestion arises as venous outflow is obstructed by rising intraorbital pressure (<a href="./references#CD007114-bbs2-0011" title="BahnRS . Graves' ophthalmopathy. New England Journal of Medicine2010;362(8):726‐38. ">Bahn 2010</a>). </p> <p>The initial active phase of TED is typically followed, after one to three years, by an inactive 'burnt out' phase during which fibrosis and scarring of the orbital contents occurs (<a href="./references#CD007114-bbs2-0042" title="RundleF , WilsonC . Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clinical Science1945;5:177‐94. ">Rundle 1945</a>). Hence, there is an early window of opportunity to modify the natural history of the disease by suppressing the immune response, and corticosteroids have been used to treat TED for over 40 years with response rates of 63% to 77% (<a href="./references#CD007114-bbs2-0012" title="BartalenaL , PincheraA , MarcocciC . Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews2000;21(2):168‐99. ">Bartalena 2000</a>). Additional immunomodulatory therapies may also be used in some centres, but there is little evidence regarding their efficacy. </p> <p>A key challenge in the management of TED is reliably differentiating between active and 'burnt out' disease (<a href="./references#CD007114-bbs2-0020" title="The European Group of Graves' Orbitopathy, PerrosP , BaldeschiL , BoboridisK , DickinsonAJ , HulloA , KahalyGJ , et al. A questionnaire survey on the management of Graves' orbitopathy in Europe. European Journal of Endocrinology2006;155(2):207‐11. ">EUGOGO 2006b</a>), and the diagnostic classification most commonly used for this purpose is the clinical activity score (CAS), which has an 80% positive‐predictive value for the outcome of immunosuppressive treatment (<a href="./references#CD007114-bbs2-0033" title="MouritsMP , PrummelMF , WiersingaWM , KoornneefL . Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology1997;47(1):9‐14. ">Mourits 1997</a>). In addition, there are multiple grading systems for classifying disease severity (<a href="./references#CD007114-bbs2-0019" title="The European Group on Graves' Orbitopathy (EUGOGO), WiersingaWM , PerrosP , KahalyGJ , MouritsMP , BaldeschiL , BoboridisK , et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. European Journal of Endocrinology2006;155(3):387‐9. ">EUGOGO 2006a</a>) based on cumulative functional and anatomical measures (<a href="./references#CD007114-bbs2-0037" title="PerrosP , CrombieAL , MatthewsJN , Kendall‐TaylorP . Age and gender influence the severity of thyroid‐associated ophthalmopathy: a study of 101 patients attending a combined thyroid‐eye clinic. Clinical Endocrinology1993;38(4):367‐72. ">Perros 1993</a>; <a href="./references#CD007114-bbs2-0038" title="PrummelMF , MouritsMP , BerghoutA , KrenningEP , van derGaagR , KoornneefL , et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. New England Journal of Medicine1989;321(20):1353‐9. ">Prummel 1989</a>; <a href="./references#CD007114-bbs2-0053" title="WernerSC . Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism1977;44(1):203‐4. ">Werner 1977</a>), and composite scores, which grade the success or failure of interventions using a defined number of criteria, are also commonly used in the evaluation of treatments for active TED (<a href="./references#CD007114-bbs2-0028" title="MarcocciC , BartalenaL , TandaML , ManettiL , Dell'UntoE , RocchiR , et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single‐blind, randomized study. Journal of Clinical Endocrinology and Metabolism2001;86(8):3562‐7. ">Marcocci 2001</a>; <a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). Once the disease has 'burnt out', residual abnormalities are managed surgically with operations to reduce proptosis (orbital decompression), minimise diplopia (strabismus surgery) and correct the position and appearance of the eyelids. Surgery is used in the active phase in sight‐threatening conditions that are not responding to medical therapy such as optic neuropathy or corneal ulceration/perforation. </p> </section> <section id="CD007114-sec2-0002"> <h3 class="title" id="CD007114-sec2-0002">Description of the intervention</h3> <p>Orbital radiotherapy has been used to treat TED for over 60 years (<a href="./references#CD007114-bbs2-0012" title="BartalenaL , PincheraA , MarcocciC . Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews2000;21(2):168‐99. ">Bartalena 2000</a>). Treatment is administered on an outpatient basis, typically involving 10 to 12 visits over a 2‐ to 2.5‐week period. The dose given is traditionally 20 Gy divided in 2 Gy fractions (<a href="./references#CD007114-bbs2-0030" title="MarquezSD , LumBL , McDougallIR , KatkuriS , LevinPS , MacManusM , et al. Long‐term results of irradiation for patients with progressive Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics2001;51(3):766‐74. ">Marquez 2001</a>) but some centres do use lower doses. Great care is taken to ensure that exposure is limited to the orbits. In some centres a plastic face shell is made for each patient to ensure that their position does not change between treatment sessions. </p> </section> <section id="CD007114-sec2-0003"> <h3 class="title" id="CD007114-sec2-0003">How the intervention might work</h3> <p>Radiotherapy is thought to reduce inflammation by preventing the replication of lymphocytes through disruption of their DNA. At the low doses used in the treatment of TED it may also specifically downregulate orbital macrophage activation (<a href="./references#CD007114-bbs2-0025" title="HildebrandtG , SeedMP , FreemantleCN , AslamCAS , Colville‐NashPR , TrottKR . Mechanisms of the anti‐inflammatory activity of low‐dose radiation therapy. International Journal of Radiation Biology1998;74(3):367‐78. ">Hildebrandt 1998</a>). In addition, radiotherapy reduces the production of water‐attracting molecules (glycosaminoglycans), which are overexpressed in TED and therefore helps to counteract orbital fluid retention and consequently tissue swelling is reduced (<a href="./references#CD007114-bbs2-0026" title="KahalyG , BeyerJ . Immunosuppressant therapy of thyroid eye disease. Klinische Wochenschrift1988;66(21):1049‐59. ">Kahaly 1988</a>). </p> </section> <section id="CD007114-sec2-0004"> <h3 class="title" id="CD007114-sec2-0004">Why it is important to do this review</h3> <p>There is great controversy about the benefits of radiotherapy for TED (<a href="./references#CD007114-bbs2-0013" title="BartalenaL , MarcocciC , PincheraA . Orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):13‐4. ">Bartalena 2004</a>; <a href="./references#CD007114-bbs2-0021" title="FeldonSE . Radiation therapy for Graves' ophthalmopathy: trick or treat?. Ophthalmology2001;108(9):1521‐2. ">Feldon 2001</a>). The evidence for its use is largely based on retrospective and uncontrolled studies, which suggest that 60% of patients have a positive response (<a href="./references#CD007114-bbs2-0012" title="BartalenaL , PincheraA , MarcocciC . Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews2000;21(2):168‐99. ">Bartalena 2000</a>), but it is difficult to ascertain whether this is a direct result of treatment or simply a reflection of expected clinical improvement in the regressive phase of the disease. The few available randomised controlled trials (RCTs) are of varying quality and have reported conflicting results (<a href="./references#CD007114-bbs2-0007" title="GormanCA , GarrityJA , FatourechiV , Bahn , RS , PetersenIA , StaffordSL , et al. A prospective, randomized, double‐blind, placebo‐controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology2001;108(9):1523‐34. ">Gorman 2001</a>; <a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). Consequently, clinical practice varies widely across the UK, Europe (<a href="./references#CD007114-bbs2-0020" title="The European Group of Graves' Orbitopathy, PerrosP , BaldeschiL , BoboridisK , DickinsonAJ , HulloA , KahalyGJ , et al. A questionnaire survey on the management of Graves' orbitopathy in Europe. European Journal of Endocrinology2006;155(2):207‐11. ">EUGOGO 2006b</a>) and in the USA. This is widely acknowledged in the literature, but an international study has not been carried out. The National Institute for Health and Clinical Excellence (NICE) have produced guidelines for the use of orbital radiotherapy in TED and have only recommended its use where other treatments have failed or have caused significant side effects (<a href="./references#CD007114-bbs2-0035" title="National Institute for Health and Clinical Excellence. Retrobulbar irradiation for thyroid eye disease. www.nice.org.uk/ip257overview 2005 (accessed March 2012). ">NICE guidelines 2005</a>). A systematic review is required to raise the standard of information available to both patients and healthcare professionals. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007114-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007114-sec1-0002"></div> <p>To review current evidence from RCTs for the effectiveness and short‐term adverse events of orbital radiotherapy in adult TED when compared to sham radiotherapy, other interventions and glucocorticoids. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007114-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007114-sec1-0003"></div> <section id="CD007114-sec2-0005"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007114-sec3-0001"> <h4 class="title">Types of studies</h4> <p>We included RCTs with a minimum of three months follow‐up and an endpoint of two years or less post treatment. Paired and unpaired studies were analysed separately. </p> </section> <section id="CD007114-sec3-0002"> <h4 class="title">Types of participants</h4> <p>We included adults (aged 18 years old or above) with clinically diagnosed TED.</p> </section> <section id="CD007114-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>We included:</p> <p> <ul id="CD007114-lst1-0001"> <li> <p>orbital radiotherapy of any dose and duration versus sham radiotherapy</p> </li> <li> <p>orbital radiotherapy of any dose and duration versus other interventions</p> </li> <li> <p>orbital radiotherapy combined with glucocorticoids versus glucocorticoids alone</p> </li> </ul> </p> </section> <section id="CD007114-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD007114-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p>We considered primary outcomes at a minimum of three months and a maximum of two years post treatment. </p> <p> <ul id="CD007114-lst1-0002"> <li> <p>Composite Outcome Score (<a href="./references#CD007114-bbs2-0028" title="MarcocciC , BartalenaL , TandaML , ManettiL , Dell'UntoE , RocchiR , et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single‐blind, randomized study. Journal of Clinical Endocrinology and Metabolism2001;86(8):3562‐7. ">Marcocci 2001</a>; <a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) ‐ ordinal score. </p> </li> </ul> </p> <p>Composite scores grade clinical success or failure using a defined number of criteria (see <a href="#CD007114-tbl-0006">Table 1</a>). Success and failure were defined by the individual trials as composite scores are heterogeneous. Our outcome was the proportion of successes compared to the proportion of non‐responders and treatment failures. </p> <div class="table" id="CD007114-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Composite outcome score criteria</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Major criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Changes in the maximum eye movement in specified directions (measured in degrees, ≥ 8 degrees) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in Gorman diplopia score <br/> (none ‐ no double vision, intermittent ‐ double vision when tired or reported but not evident, inconstant ‐ double vision in certain directions of gaze, constant ‐ double vision in primary position or requiring a prism) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in visual acuity (Snellen acuity or converted Snellen acuity) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in soft tissue inflammation (predefined change in the appearance of the eyelids, conjunctiva, caruncle (which is the pink tissue in the medial corner of the eye), or a combination graded mild (1), moderate (2) or severe (3) according to a standardised colour atlas (<a href="./references#CD007114-bbs2-0017" title="DickinsonAJ , PerrosP . Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clinical Endocrinology2001;55(3):283‐303. ">Dickinson 2001</a>) or eyelid swelling alone (none, mild, moderate, severe) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change of palpebral/lid aperture (distance between upper and lower eyelid at the point midway across the pupil) of &gt; 2 mm </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in proptosis (protrusion of eyeball) of &gt; 2 mm </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in CAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subjective improvement (predefined grading)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Used in more than 1 study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a> </p> <p> <ul id="CD007114-lst1-0020"> <li> <p>Success = improvement in 1 or more major criterion or 2 minor criteria</p> </li> <li> <p>Failure = success definition not met</p> </li> </ul> </p> <p><a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a> </p> <p> <ul id="CD007114-lst1-0021"> <li> <p>Very good outcome = an improvement in at least 2 major criteria</p> </li> <li> <p>Good outcome = improvement of 1 major criterion</p> </li> <li> <p>Fair outcome = improvement of 2 minor criteria</p> </li> <li> <p>No change = no change in criteria or improvement of 1 minor criterion</p> </li> <li> <p>Worse = deterioration of at least 1 major criterion or 2 minor criteria</p> </li> </ul> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CAS: clinical activity score</p> </div> </div> </section> <section id="CD007114-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p>We considered secondary outcomes at a minimum of three months and a maximum of two years post treatment. </p> <p> <ul id="CD007114-lst1-0003"> <li> <p>Number of post‐treatment rehabilitative surgical procedures to correct functional disability (e.g. eyelid operations to reduce exposure of the cornea, squint operations for double vision, orbital decompression operations to reduce the proptosis) </p> </li> </ul> <ul id="CD007114-lst1-0004"> <li> <p>Disease Severity Score ‐ total eye score (see <a href="#CD007114-tbl-0007">Table 2</a>) (<a href="./references#CD007114-bbs2-0038" title="PrummelMF , MouritsMP , BerghoutA , KrenningEP , van derGaagR , KoornneefL , et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. New England Journal of Medicine1989;321(20):1353‐9. ">Prummel 1989</a>) ‐ a continuous score </p> <div class="table" id="CD007114-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Modified NOSPECS and total eye score (TES)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NOSPECS class</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>TES equivalent</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No signs or symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only signs (lid retraction, lid lag)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: absent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: minimal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: marked</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proptosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: &lt; 20 mm</p> <p>(original score &lt; 23 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: 20 to 21 mm</p> <p>(original score 23 to 24 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: 21.5 to 24 mm</p> <p>(original score 25 to 27 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: &gt; 24 mm</p> <p>(original score &gt; 28 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eye muscle involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: absent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: limitation in extremes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: evident restriction of movement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: fixation of globes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Corneal involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: absent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: stippling/staining of cornea with fluorescein drops</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: ulceration of cornea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: clouding, necrosis, perforation of cornea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sight loss (Snellen acuity stated in American units)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 0: better than 20/30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class a: 20/30 to 20/60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class b: 20/60 to 20/200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class c: worse than 20/200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual class values added together to give total eye score</p> </td> </tr> </tbody> </table> </div> </li> </ul> </p> <p>(NOSPECS score, an ordinal score, (<a href="./references#CD007114-bbs2-0053" title="WernerSC . Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism1977;44(1):203‐4. ">Werner 1977</a>) or Ophthalmopathy index, a continuous score (<a href="./references#CD007114-bbs2-0037" title="PerrosP , CrombieAL , MatthewsJN , Kendall‐TaylorP . Age and gender influence the severity of thyroid‐associated ophthalmopathy: a study of 101 patients attending a combined thyroid‐eye clinic. Clinical Endocrinology1993;38(4):367‐72. ">Perros 1993</a>), if total eye score not present), which assess how severe the changes due to TED are (see <a href="#CD007114-tbl-0007">Table 2</a>; <a href="#CD007114-tbl-0008">Table 3</a>). </p> <div class="table" id="CD007114-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Ophthalmopathy index</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Involvement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Score</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Soft tissue involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>Proptosis (in mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="11" valign="top"> <p>Palpebral aperture (distance between upper and lower eyelids at mid‐pupil point) (in mm) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.95</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="10" valign="top"> <p>Difference between intraocular pressure looking straight ahead and that in upgaze</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Diplopia (double vision)</p> <p>(grades defined in composite score table)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intermittent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inconstant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Constant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Corneal involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Initial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clouding/perforation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Optic neuropathy (optic nerve damage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Abnormal visual evoked potential detected when vision better than 6/12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>(Snellen visual acuity expressed as fraction (e.g. 6/12 = 0.5))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 to 0.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1 to 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> </tbody> </table> </div> <p> <ul id="CD007114-lst1-0005"> <li> <p>Disease Activity Score ‐ CAS (<a href="./references#CD007114-bbs2-0032" title="MouritsMP , KoornneefL , WiersingaWM , PrummelMF , BerghoutA , van derGaagR . Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. British Journal of Ophthalmology1989;73(8):639‐44. ">Mourits 1989</a>), a continuous score that assesses how active the disease is (see <a href="#CD007114-tbl-0009">Table 4</a>). </p> <div class="table" id="CD007114-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Clinical activity score</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>(Each score 1 point)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain on eye movement in the last 4 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Painful, oppressive feeling on or behind eye globe in the last 4 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Redness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conjunctival redness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eyelid redness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Swelling</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chemosis (fluid under conjunctiva)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Swollen caruncle (pink tissue in medial corner of eye next to nose)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eyelid oedema</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increasing proptosis of &gt; 2 mm during a period of 1 to 3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Impaired function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreasing visual acuity of &gt; 1 Snellen line (using a pinhole to obtain best corrected visual acuity) during a period of 1 to 3 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreasing eye movement of greater than or equal to 5 degrees during a period of 1 to 3 months </p> </td> </tr> </tbody> </table> </div> </li> </ul> </p> <section id="CD007114-sec5-0001"> <h6 class="title">Adverse outcomes</h6> <p> <ul id="CD007114-lst1-0006"> <li> <p>Adverse events (e.g. reaction to trial medication, effect on patient's liver function or full blood count, development of secondary ocular or non‐ocular disorders such as cataracts, retinopathy, head and neck malignancy in particular lymphoma) </p> </li> </ul> <ul id="CD007114-lst1-0007"> <li> <p>Study withdrawal due to intolerance of study intervention</p> </li> </ul> </p> </section> <section id="CD007114-sec5-0002"> <h6 class="title">Economic data</h6> <p>We summarised the direct and indirect costs of rehabilitative interventions such as surgery and medical treatments and any other economic data in the included studies. </p> </section> <section id="CD007114-sec5-0003"> <h6 class="title">Quality‐of‐life data</h6> <p>Quality‐of‐life measurement (a continuous score) was summarised using validated questionnaires available from individual studies (<a href="./references#CD007114-bbs2-0048" title="TerweeCB , DekkerFW , MouritsMP , GerdingMN , BaldeschiL , KalmannR , et al. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO‐QOL) after different treatments. Clinical Endocrinology2001;54(3):391‐8. ">Terwee 2001</a>). </p> </section> </section> </section> </section> <section id="CD007114-sec2-0006"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007114-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2012, Issue 2, part of <i>The Cochrane Library</i>. <a href="http://www.thecochranelibrary.com/" target="_blank">www.thecochranelibrary.com</a> (accessed 12 March 2012), MEDLINE (January 1950 to March 2012), EMBASE (January 1980 to March 2012), Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to March 2012), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not restrict the search for trials by language or date. We last searched the electronic databases on 12 March 2012. </p> <p>See: Appendices for details of search strategies for CENTRAL (<a href="./appendices#CD007114-sec2-0016">Appendix 1</a>), MEDLINE (<a href="./appendices#CD007114-sec2-0017">Appendix 2</a>), EMBASE (<a href="./appendices#CD007114-sec2-0018">Appendix 3</a>), LILACS (<a href="./appendices#CD007114-sec2-0019">Appendix 4</a>), <i>m</i>RCT (<a href="./appendices#CD007114-sec2-0020">Appendix 5</a>), ClinicalTrials.gov (<a href="./appendices#CD007114-sec2-0021">Appendix 6</a>) and the ICTRP (<a href="./appendices#CD007114-sec2-0022">Appendix 7</a>). </p> </section> <section id="CD007114-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of reports of included studies, other reviews and book chapters to find references to additional trials. We contacted trial investigators and experts in the field to identify additionally published and unpublished studies. </p> </section> </section> <section id="CD007114-sec2-0007"> <h3 class="title" id="CD007114-sec2-0007">Data collection and analysis</h3> <section id="CD007114-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed the titles and abstracts of all reports identified by the searches. RR and SM worked independently to screen the titles and abstracts that resulted from the searches. Each report was labelled as (a) definitely exclude, (b) unsure or (c) definitely include. The full texts of abstracts labelled as 'unsure' were reassessed according to the inclusion criteria for this review. Differences between the two review authors' assessments were resolved through discussion or by involving a third person to adjudicate. Studies labelled as 'definitely exclude' were excluded from the review and those labelled as 'definitely include' were assessed for methodological quality. Trial authors were contacted for clarification where necessary. Attempts were made to obtain further information about any trial that had been published only as an abstract. If a full report was not available, the abstract was excluded at this stage. </p> </section> <section id="CD007114-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>RR and SM worked independently to extract the following information from the trial reports and entered the data into RevMan (<a href="./references#CD007114-bbs2-0040" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">Review Manager 2011</a>): </p> <p> <ul id="CD007114-lst1-0008"> <li> <p>details of participants: age, gender, setting, number in each group, comparability at baseline </p> </li> <li> <p>details of interventions: dosage, schedule, comparison group</p> </li> <li> <p>outcomes: primary and secondary outcomes, adverse effects</p> </li> <li> <p>other information: funding</p> </li> <li> <p>primary and secondary outcome data. If reports used different methods for assessing outcomes, the method described most often was selected for analysis and all other measurements were converted where possible </p> </li> </ul> </p> </section> <section id="CD007114-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>As per guidance given in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007114-bbs2-0024" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) we examined the following different types of biases: selection, performance, detection and attrition by assessing randomisation, concealment of allocation and blinding (masking). </p> <p>Two review authors working independently assessed trial quality as follows:</p> <p>1. The method that was used to generate the random sequence within the trials was graded as follows: </p> <p> <ul id="CD007114-lst1-0009"> <li> <p>(A) low risk: computer random number generator, random number table, shuffled cards or envelopes </p> </li> <li> <p>(B) unclear: not stated in report</p> </li> <li> <p>(C) high risk: no sequence or alternation, case record numbers, dates of birth, days of the week </p> </li> </ul> </p> <p>Any trial graded as (C) on randomisation was excluded.</p> <p>2. Allocation concealment: the mechanism of implementing the randomisation schedule was graded as follows: </p> <p> <ul id="CD007114-lst1-0010"> <li> <p>(A) low risk: centralized randomisation by central office or pharmacy, sequential administration of pre‐numbered or coded containers to enrolled participants, on‐site computer system (provided that the computer file containing the assignments is locked), serially numbered sealed opaque envelopes, other approaches that appear to offer adequate concealment, combined with the statement that the person who generated the allocation did not administer it </p> </li> <li> <p>(B) unclear: list, table or envelopes used but no qualifying statement, an apparently adequate concealment but other information in the report suggests that concealment may not have been adequate </p> </li> <li> <p>(C) high risk: any allocation that is entirely transparent before allocation.</p> </li> </ul> </p> <p>3. Blinding (masking)</p> <p>We assessed masking of participants, providers of care and outcome assessment (for each outcome). Each of these were graded: </p> <p> <ul id="CD007114-lst1-0011"> <li> <p>(A) low risk</p> </li> <li> <p>(B) unclear</p> </li> <li> <p>(C) high risk</p> </li> </ul> </p> <p>4. Incomplete outcome data assessed</p> <p>We documented missing outcome data and exclusions from the analysis. Trials were graded according to whether the analysis was intention‐to‐treat (ITT) as follows: </p> <p> <ul id="CD007114-lst1-0012"> <li> <p>(A) low risk: ITT done</p> </li> <li> <p>(B) unclear</p> </li> <li> <p>(C) high risk: ITT not done</p> </li> </ul> </p> <p>We were not masked to trial results or publication details during the quality assessment. Disagreements between review authors were documented and discussed. Study authors were contacted for clarification on any item scored 'unclear', or where there was disagreement between authors on the grading. </p> </section> <section id="CD007114-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>Our primary outcome measure was success defined by a composite outcome score. We used risk ratios (RRs) as our measure of treatment effect. Information on secondary outcomes was only collated. </p> </section> <section id="CD007114-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <p>Studies using both eyes of participants were analysed separately to those where a single eye had been studied and compared to the other eye. As TED is a systemic condition and treatment has an effect systemically, those trials using observation of one eye compared to the other in the same individual are likely to find differing results to those comparing one participant with another acting as a control (the radiotherapy could have had an effect on the control eye both by direct low‐dose unintentional radiation of the contralateral orbit and by the radiotherapy acting on lymphocytes that could circulate to the other orbit). </p> <p>Composite scores, disease activity and disease severity were assessed on highest scoring eye. Quality of life, economic data and adverse events were assessed on the individual. </p> </section> <section id="CD007114-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>Where possible investigators were contacted if there were missing data. Any missing data that was unobtainable were assumed to be 'missing at random'. </p> </section> <section id="CD007114-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed for heterogeneity between studies by careful review of papers to identify important methodological differences that might lead to methodological heterogeneity. If the studies appeared similar, we assessed consistency between them by examination of the I<sup>2</sup> statistic. If the I<sup>2</sup> statistic was less than 50% and no clinical heterogeneity had been determined we performed a meta‐analysis where studies had collected data on the primary endpoint. </p> </section> <section id="CD007114-sec3-0014"> <h4 class="title">Assessment of reporting biases</h4> <p>We aimed to investigate the potential influence of publication bias by examining funnel plots, but as there were insufficient eligible trials this could not be done. </p> </section> <section id="CD007114-sec3-0015"> <h4 class="title">Data synthesis</h4> <p>We used the individual trial's predefined success and failure and compared the proportion of patients/eyes who improved to those that remained the same or worsened. The RRs for dichotomous data model were used when meta‐analyzing the data. In general we used the random‐effects model unless there were fewer than three trials when the fixed‐effect model was used. </p> </section> <section id="CD007114-sec3-0016"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If the studies were inconsistent in how they assessed their outcomes or if heterogeneity was detected we did not pool the data but instead presented a narrative review. Heterogeneity of all forms was assessed as indicated in the '<a href="#CD007114-sec3-0013">Assessment of heterogeneity</a>' section. </p> </section> <section id="CD007114-sec3-0017"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analyses to assess the robustness of results when we: <br/> 1. excluded studies of lower methodological quality (scoring C (high risk) on randomisation) <br/> 2. excluded unpublished studies </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007114-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007114-sec1-0004"></div> <section id="CD007114-sec2-0008"> <h3 class="title">Description of studies</h3> <section id="CD007114-sec3-0018"> <h4 class="title">Results of the search</h4> <p>The electronic searches yielded a total of 567 reports of studies (<a href="#CD007114-fig-0001">Figure 1</a>). After deduplication the Trials Search Co‐ordinator scanned 401 records and discarded 249 records because they were not relevant to the scope of the review. We screened the title and abstracts of the remaining 152 references. Of these records 22 were in Spanish, one author (SM) reviewed the Spanish abstracts and we excluded all of these abstracts as none met the inclusion criteria. Of the remaining 130 abstracts we excluded 17 as they were review papers. We reviewed the remaining reports and 15 abstracts related to RCTs comparing radiotherapy to sham treatment or to another intervention were potentially eligible for inclusion. We excluded trials comparing different dosing regimens of radiotherapy as they did not meet our inclusion criteria. Of the 15 eligible abstracts, one was a comment on a randomised trial and five were duplicate reports, leaving nine studies for detailed review. We obtained the full papers for these and two review authors (RR and SM) reviewed them independently. Any discrepancies were discussed between the two review authors, and a third review author (CB) was consulted if they were not resolved. At this stage, we excluded four further studies; one that used adjuvant steroids in the radiotherapy arm of the study only (<a href="http://archie.cochrane.org/sections/documents/view?version=59641867958627465058101028123129%26format=REVMAN#STD-Antonelli-1992" target="_blank">Antonelli 1992</a>), and one that used the patient's untreated eye as the control arm with subsequent cross‐over treatment (<a href="./references#CD007114-bbs2-0007" title="GormanCA , GarrityJA , FatourechiV , Bahn , RS , PetersenIA , StaffordSL , et al. A prospective, randomized, double‐blind, placebo‐controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology2001;108(9):1523‐34. ">Gorman 2001</a>). In the latter, the radiotherapy could have had an effect on the control eye both by direct low‐dose unintentional radiation of the contralateral orbit and by the radiotherapy acting on lymphocytes, which could circulate to the other orbit and have had an effect on the control eye and, as such, the controls were not suitably independent. One study (<a href="./references#CD007114-bbs2-0009" title="SterkerI , TegetmeyerH , PapsdorfK , Fuhrer‐SakelD . Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves' orbitopathy. Hormone and Metabolic Research2009;41(5):391‐6. ">Sterker 2009</a>) was excluded as it was a retrospective study. Another study (<a href="./references#CD007114-bbs2-0008" title="LiLL , WangF , ZhangY , SunR . Observation of curative effect of triamcinolone acetomide retrobular injection combined with orbital radiation on TAO. International Journal of Ophthalmology2008;8(9):1860‐2. ">Li 2008</a>) stated that participants were randomly divided into treatment groups. We contacted the trialists for further details but were informed that the study was not an RCT. </p> <div class="figure" id="CD007114-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Results from searching for studies for inclusion in the review." data-id="CD007114-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review.</p> </div> </div> </div> <p>This left five trials that met the inclusion criteria. The characteristics of these studies and the quality of the studies are described below. </p> </section> <section id="CD007114-sec3-0019"> <h4 class="title">Included studies</h4> <p>See the '<a href="./references#CD007114-sec2-0025" title="">Characteristics of included studies</a>' table for further details. </p> <section id="CD007114-sec4-0003"> <h5 class="title">Participants</h5> <p>The five included RCTs randomised a total of 244 participants (sample size range 16 to 88). Of these 199 were female. The mean age in the radiotherapy group ranged from 42 to 64 years old, and from 45 to 49 years old in the comparison group. The number of smokers was not reported in the earliest two studies (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>), but ranged from 31.2% to 66.7% in the latter three (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). Treatment of TED prior to the study was an exclusion criterion in four out of the five studies and was not reported on in one study (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>). Treated patients had moderately severe TED in four studies and mild TED in one study. Presence of optic neuropathy was an exclusion criterion in three studies (<a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>; <a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>) and was only included in one study if the patient refused surgery or surgery was contraindicated (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). In the earliest study (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>) the inclusion of participants with optic neuropathy was not specified but in the data given two patients in the radiotherapy group had sight loss from optic nerve involvement and none of the control group did. </p> </section> <section id="CD007114-sec4-0004"> <h5 class="title">Types of interventions</h5> <p>Orbital radiotherapy was compared to sham treatment in two studies (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and compared to glucocorticoid treatment in three studies (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>). Two of these studies involved glucocorticoid administration to the radiotherapy arm of the study as well as the control (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). </p> </section> <section id="CD007114-sec4-0005"> <h5 class="title">Types of outcome measures</h5> <p>Two studies used a composite outcome score (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and two used the NOSPECS and total eye scores (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>). The ophthalmopathy score was only used in one study (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>). The CAS was described in 1997 and therefore not used in the earlier two studies (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>). However, two later studies did use CAS as an outcome (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). Only one study used the Graves Ophthalmopathy ‐ Quality of Life questionnaire (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and three recorded the Subjective Eye Score (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>). Health economic data was reported in one trial (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). </p> <p>Final outcomes were assessed at different time points. Two studies used 24 weeks as the final endpoint (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>) and two assessed the outcome at one year (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). The earliest study (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>) did not define a specific time point and instead used the final follow‐up subsequent to discontinuation of steroid. This ranged from 12 to 28 months, with a mean of 19 months, in the randomised combination therapy group, and 18 months in the steroid control group. The treatment itself lasted five to six months making the total follow‐up from the start of treatment range from 17 to 34 months. </p> </section> </section> <section id="CD007114-sec3-0020"> <h4 class="title">Excluded studies</h4> <p>We excluded four studies (<a href="./references#CD007114-bbs2-0006" title="AntonelliA , SaracinoA , AlbertiB , CanapicchiR , CarteiF , LepriA , et al. High‐dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. Acta Endocrinologica1992;126(1):13‐23. ">Antonelli 1992</a>; <a href="./references#CD007114-bbs2-0007" title="GormanCA , GarrityJA , FatourechiV , Bahn , RS , PetersenIA , StaffordSL , et al. A prospective, randomized, double‐blind, placebo‐controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology2001;108(9):1523‐34. ">Gorman 2001</a>; <a href="./references#CD007114-bbs2-0008" title="LiLL , WangF , ZhangY , SunR . Observation of curative effect of triamcinolone acetomide retrobular injection combined with orbital radiation on TAO. International Journal of Ophthalmology2008;8(9):1860‐2. ">Li 2008</a>; <a href="./references#CD007114-bbs2-0009" title="SterkerI , TegetmeyerH , PapsdorfK , Fuhrer‐SakelD . Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves' orbitopathy. Hormone and Metabolic Research2009;41(5):391‐6. ">Sterker 2009</a>) and details can be found in the '<a href="./references#CD007114-sec2-0026" title="">Characteristics of excluded studies</a>' table. </p> </section> </section> <section id="CD007114-sec2-0009"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD007114-sec3-0021"> <h4 class="title">Allocation</h4> <section id="CD007114-sec4-0006"> <h5 class="title">Random sequence generation</h5> <p>Randomisation was carried out according to lists in two studies (<a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and random numbers in one study (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>). One study used an external randomisation service (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>) but the exact details of how this was carried out were not described. The most recent study (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>) stated that randomisation was used but did not report how. </p> </section> <section id="CD007114-sec4-0007"> <h5 class="title">Allocation concealment</h5> <p>Allocation concealment was adequate in two studies (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) but unclear in the remaining three (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>). </p> </section> </section> <section id="CD007114-sec3-0022"> <h4 class="title">Blinding</h4> <p>Three studies (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) were double‐masked. The other two were single‐masked with the assessor unaware of treatment allocation (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). However, patients were aware of their allocation and this could have led to bias in their reporting of symptoms. </p> </section> <section id="CD007114-sec3-0023"> <h4 class="title">Incomplete outcome data</h4> <p><a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a> did not specifically mention dropouts, withdrawals or protocol deviations, but all patients did have an outcome reported. Authors of the steroid versus radiotherapy trial (<a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>) stated that patients without sufficient follow‐up were excluded and replaced. Two studies excluded one patient each who died or withdrew prior to the first postintervention assessment without replacement (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). An ITT analysis was carried out by two studies, including one of the above (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>), by either including protocol deviations or using the last observation carried forwards (LOCF) principle for participants who did not complete the study. In one study they stated that the LOCF was only used if patients had a minimum of four‐week post baseline data (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). </p> </section> <section id="CD007114-sec3-0024"> <h4 class="title">Selective reporting</h4> <p>One study did not have a defined temporal endpoint (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>) and therefore outcome measures were taken 17 to 34 months after the initiation of the intervention, reducing the comparability of results. Another study did not report on adverse events (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>), and, despite attempting to obtain this data directly from the study group, we were unable to do so as the first study author was deceased and the study documents destroyed.  </p> </section> </section> <section id="CD007114-sec2-0010"> <h3 class="title" id="CD007114-sec2-0010">Effects of interventions</h3> <section id="CD007114-sec3-0025"> <h4 class="title">Orbital radiotherapy versus sham treatment</h4> <p>Two studies compared orbital radiotherapy and sham treatment; one enrolling moderately active TED (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>) and one investigating treatment of mild disease (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). Our primary outcome of composite outcome score was used in both, although the major and minor criteria used were not identical. We recorded the number of patients meeting the predefined composite success criteria in both studies, the analysis of which showed an RR of success of 1.92 (95% confidence interval (CI) 1.27 to 2.91; <a href="./references#CD007114-fig-00101" title="">Analysis 1.1</a>) in favour of orbital radiotherapy. Our secondary outcome of number of rehabilitative surgeries was similar in the radiotherapy group (47; <a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a> and 27; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and the sham treatment group (45; <a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a> and 30; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) for both studies. </p> <p><a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a> also assessed the change in CAS (our co‐secondary outcome) from baseline to 12 months and found a mean reduction of ‐0.84 (standard deviation (SD) 1.15) in the orbital radiotherapy group and a mean reduction of ‐1.19 (SD 1.53) in the sham group. However, this difference was not significant (0.35; 95% CI ‐0.22 to 0.92). </p> </section> <section id="CD007114-sec3-0026"> <h4 class="title">Orbital radiotherapy versus steroids</h4> <p>Only one study was identified which randomised orbital radiotherapy without steroids to oral prednisolone (<a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>), and, as such, a meta‐analysis was not possible. The study involved patients with moderately severe TED. The primary outcome of composite outcome score was not assessed by this group but secondary outcomes of disease severity and number of rehabilitative surgeries were recorded. An improvement in NOSPECS at 24 weeks was seen in 13 out of 28 patients (46%) in the radiotherapy group and 14 out of 28 (50%) in the oral steroid group. However, this was not significant (odds ratio (OR) 0.87; 95% CI 0.30 to 2.47). The number of rehabilitative operations performed after treatment was similar between the radiotherapy and steroid groups (20 (71%) and 22 (79%), respectively). </p> </section> <section id="CD007114-sec3-0027"> <h4 class="title">Orbital radiotherapy combined with steroids versus steroids alone</h4> <p>Two studies randomised patients to orbital radiotherapy combined with oral steroids versus oral steroids in isolation to explore radiotherapy as a combination treatment as compared to steroids alone (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). Both enrolled patients with moderately active TED. As the studies did not use our primary outcome score of a composite outcome score a meta‐analysis could, once again, not be performed. Our secondary outcome of disease severity was recorded for both. However, as only one study reported the total eye score, no meta‐analysis could be performed of this (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). In addition, although both studies did use the NOSPECS score, data on the randomised patients could not be separated from that of non‐randomised patients in <a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>, preventing further comparative analysis. </p> <p><a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a> compared orbital cobalt radiotherapy with methylprednisolone to methylprednisolone alone (n = 24). However, a further 24 non‐randomised patients treated with combined radiotherapy and methylprednisolone were also reported on (total n = 48). We extracted the data on the classification of improvement and initial and final Ophthalmopathy Index on the randomised patients only. This revealed a mean reduction of ‐4.8 (SD 1.5) in the group treated with orbital radiotherapy in combination with intravenous steroids as compared to ‐3.2 (SD 0.94) in the group treated with intravenous steroids alone (P &lt; 0.005 by Student's unpaired two‐tailed t‐test); resulting in a mean difference between the groups of ‐1.60 (95% CI ‐2.60 to ‐0.60). The study group used predefined criteria to measure response, taken from a radiotherapy study carried out between 1968 and 1972 (<a href="./references#CD007114-bbs2-0018" title="DonaldsonSS , BagshawMA , KrissJP . Supervoltage orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism1973;37(2):276‐85. ">Donaldson 1973</a>). This was similar to a composite score, using changes in symptoms, signs and functional capacity, but lacking objective definitions. Bartalena et al. found an excellent response in four patients in the combination group but none in the steroid alone group. A good response was reported in six patients in the combination group compared to four in the steroid group. Slight response and no response were seen in two and none of the combination group, respectively, and six and two of the steroid alone group. By comparing an excellent and good response with a slight or no response, using a Chi<sup>2</sup> analysis, they found a significance of &lt; 0.01. </p> <p><a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a> investigated the use of intravenous steroids with and without radiotherapy in a small cohort of 16 patients and reported on 15 of them at 52 weeks (one of the steroid alone group died prior to first assessment from community acquired pneumonia). The mean age of the combination group was higher than those in the intravenous steroid group (64.1 years old versus 48.3 years old). A similar number of patients needed an increase in steroids due to deterioration of total eye score of four or more (3/7 steroid only group (43%), 4/8 combination therapy group (50%)). The improvement in NOSPECS class was greater in the combination group as compared to the control group (7/8 (88%) versus 2/7 (29%) for soft tissue changes, 7/8 (88%) versus 2/7 (29%) for ocular motility and 5/8 (63%) versus 0/7 (0%) for patients showing 'normal eye movement'). The mean change in total eye score was therefore significantly greater in the combination group (‐11.75; 95% CI ‐18.13 to ‐5.37) as opposed to the steroid monotherapy group (‐5.00; 95% CI ‐7.72 to ‐2.28) (P = 0.029). </p> <section id="CD007114-sec4-0008"> <h5 class="title">Adverse events</h5> <p>All but one study reported the adverse events experienced by their study participants (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>). These are described in the adverse events table (<a href="./references#CD007114-fig-00301" title="">Analysis 3.1</a>). Almost all of these related to steroid treatment with only three cases of transient redness of the skin and two cases of transient local hair loss reported with radiotherapy. One study, looking at prednisolone versus radiotherapy, commented that their follow‐up was too short for detecting long‐term radiotherapy side effects (<a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>). There were no comments on development of retinopathy. Of the five studies, three excluded patients with diabetes (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and one excluded patients with pre‐existing diabetic retinopathy (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). <a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a> did not state that they excluded diabetics and 'retinoscopy' (fundoscopy) was performed as they assessed optic nerve changes. In their report of side effects there was no comment on development of radiation retinopathy or diabetic retinopathy. </p> </section> <section id="CD007114-sec4-0009"> <h5 class="title">Quality‐of‐life assessment</h5> <p>One study did attempt to assess the change in the quality of life using the GO‐QoL (Graves Ophthalmopathy ‐ Quality of Life), Euro‐QoL, SIP (Sickness Impact Profile) and MOS‐24 (Medical Outcomes Study Short‐form General Health Survey) questionnaires (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). They were unable to assess the first 23 of their 88 patients and, in the remaining patients, the response rate at baseline was 92% and that at 12 months was 85%. As they had incomplete data on 42% of patients their quality‐of‐life assessment lacked power for further analysis. However, there was no obvious difference in quality of life between those treated with radiotherapy and those who received sham radiotherapy. The subjective eye score recorded in one study comparing radiotherapy to steroids (<a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>), and one comparing combination radiotherapy/steroid treatment to steroids alone (<a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>) was slightly higher in the control arm (1.3 versus 1.2, 1 versus 0.8). However, this was not significant. </p> </section> <section id="CD007114-sec4-0010"> <h5 class="title">Health economic analysis</h5> <p>Only one study (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) reviewed the cost of management of mild TED with radiotherapy treatment and without. Their estimated costs of radiotherapy and follow‐up care during the first year after such treatment were Euros 5007 per person for radiotherapy and Euros 4465 per person for sham. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007114-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007114-sec1-0005"></div> <section id="CD007114-sec2-0011"> <h3 class="title" id="CD007114-sec2-0011">Summary of main results</h3> <p>This Cochrane review has demonstrated that there is great heterogeneity of outcome measures used in TED treatment trials. This has prevented a meta‐analysis using data from all of the identified studies. Only two studies could be combined, both investigating radiotherapy versus sham treatment in mild‐to‐moderate thyroid‐associated orbitopathy (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). The proportion of patients reaching predefined success criteria as defined by the composite outcome score was found to favour treatment with radiotherapy in this setting (RR 1.92; 95% CI 1.27 to 2.91). However, the proportion of rehabilitative procedures necessary was similar between the two groups. The only included RCT comparing radiotherapy to oral prednisolone, also in mild‐to‐moderate patients, did not demonstrate a difference between disease progression or the number of rehabilitative procedures required by patients, in the two groups, suggesting that radiotherapy was as effective as steroid monotherapy. </p> <p>Two studies compared treatment with radiotherapy plus steroids versus steroids alone (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>; <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a>). Although these studies could not be combined due to differences in outcome measures, the number of patients who improved in NOSPECS, Ophthalmopathy index or total eye score was greater in the combination therapy group than the steroid monotherapy group in both cases. This difference was found to be statistically significant in one study. Although one of these studies did enrol two patients with severe sight‐threatening disease (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>), this was insufficient to comment on the effect of radiotherapy on this subgroup. </p> <p>The effect on quality of life was difficult to assess. Validated questionnaires were used in one study (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and due to poor response they did not have sufficient power for analysis. Review of the scores did not reveal an obvious trend in quality‐of‐life difference between the two groups. Costs of treatment were only assessed in one study, which showed that in mild disease the cost of radiotherapy was 12% greater than sham treatment. </p> <p>Adverse events were common but mild, and were almost always attributable to the steroids involved in the trials. Radiotherapy was found to have local short‐term adverse events such as transient loss of hair or redness. The only two systemic short‐term adverse events reported with radiotherapy (weight gain and leukocytosis) were seen in both the treatment and control arms of the studies involved, suggesting that they may not have been directly related to the radiotherapy. Development of retinopathy was not reported on in any of the five studies. Four studies excluded diabetic patients or those with pre‐existing diabetic retinopathy and this may have affected the incidence of retinal changes. The follow‐up of these studies was too short to confirm or dispute the theoretical risk of induction of malignancies with radiotherapy. </p> <p>In summary, this review has found that orbital radiotherapy is more effective than sham radiotherapy for the treatment of mild‐to‐moderate TED and that a difference between radiotherapy and steroid monotherapy was not found in any single trial. One of our secondary outcomes of disease severity (total eye score, NOSPECS score and Ophthalmopathy index) also suggested a better outcome of combination treatment with steroids versus steroids alone, although a large meta‐analysis looking at this aspect was not possible. However, significant changes in quality‐of‐life scores following treatment with radiotherapy versus alternative treatments were not found. Short‐term adverse events related to radiotherapy were local and mild supporting its safe use although long‐term data are lacking and the development of retinal changes was not reported on. </p> </section> <section id="CD007114-sec2-0012"> <h3 class="title" id="CD007114-sec2-0012">Overall completeness and applicability of evidence</h3> <p>The studies described above relate to patients with mild or moderate TED. Patients with severe TED, including those with optic neuropathy, were excluded in three trials (<a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a>; <a href="./references#CD007114-bbs2-0004" title="PrummelMF , MouritsMP , BlankL , BerghoutA , KoornneefL , WiersingaWM . Randomized double‐blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet1993;342(8877):949‐54. ">Prummel 1993</a>; <a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>) and included in <a href="./references#CD007114-bbs2-0003" title="NgCM , YuenHK , ChoiKL , ChanMK , YuenKT , NgYW , et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate‐to‐severe Graves' ophthalmopathy: a preliminary study. Hong Kong Medical Journal2005;11(5):322‐30. ">Ng 2005</a> if the patient refused surgery or surgery was contraindicated. The study that included all TED severities only had two patients with optic neuropathy, both of which were in the combination‐treatment group (<a href="./references#CD007114-bbs2-0001" title="BartalenaL , MarcocciC , ChiovatoL , LaddagaM , LepriG , AndreaniD , et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Journal of Clinical Endocrinology and Metabolism1983;56(6):1139‐44. ">Bartalena 1983</a>). </p> <p>Adverse events were documented in four of five studies. Although most of the effects relating to radiotherapy were infrequent, local and mild, the numbers involved in these studies were insufficient to comment on the risks of radiotherapy accurately. Furthermore, many of the reported effects of radiotherapy are long‐term and would not necessarily have been appreciated during the two‐year study period. As such, this review fails to inform about rare but significant complications of orbital radiotherapy adequately. </p> <p>The issue of long‐term side effects of orbital radiotherapy has been addressed in four studies involving a total of 597 participants (<a href="./references#CD007114-bbs2-0023" title="GormanCA , GarrityJA , FatourechiV , BahnRS , PetersenIA , StaffordSL , et al. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology2002;109(11):2100‐7. ">Gorman 2002</a>; <a href="./references#CD007114-bbs2-0029" title="MarcocciC , BartalenaL , RocchiR , MarinoM , MenconiF , MorabitoE , et al. Long‐term safety of orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2003;88(8):3561‐6. ">Marcocci 2003</a>; <a href="./references#CD007114-bbs2-0030" title="MarquezSD , LumBL , McDougallIR , KatkuriS , LevinPS , MacManusM , et al. Long‐term results of irradiation for patients with progressive Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics2001;51(3):766‐74. ">Marquez 2001</a>; <a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a>). Of these studies, three were uncontrolled. One (<a href="./references#CD007114-bbs2-0023" title="GormanCA , GarrityJA , FatourechiV , BahnRS , PetersenIA , StaffordSL , et al. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology2002;109(11):2100‐7. ">Gorman 2002</a>) was a continuation of an RCT of orbital radiotherapy in TED that was excluded from this review due to trial design. The authors reviewed the 37 surviving patients out of the 42 enrolled in the trial at three years. Two patients died of non‐head and neck cancer, one was lost to follow‐up and two could not participate. Of the remaining three studies, only one used a control group of patients treated with other modalities (<a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a>). The range of mean follow‐up for the four studies was three to 11 years (with one study including patients with up to 29 years follow‐up). No head or neck tumours developed during the follow‐up period in any study. In one study two patients died of haematological malignancies (<a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a>) but one was in the irradiated group and one in the non‐irradiated group. The incidence of cataract development was reported in three of the studies and ranged from 10% to 34% (<a href="./references#CD007114-bbs2-0029" title="MarcocciC , BartalenaL , RocchiR , MarinoM , MenconiF , MorabitoE , et al. Long‐term safety of orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2003;88(8):3561‐6. ">Marcocci 2003</a>; <a href="./references#CD007114-bbs2-0030" title="MarquezSD , LumBL , McDougallIR , KatkuriS , LevinPS , MacManusM , et al. Long‐term results of irradiation for patients with progressive Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics2001;51(3):766‐74. ">Marquez 2001</a>; <a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a>). The highest value was actually found in non‐irradiated patients in one study, with irradiated patients manifesting a cataract incidence of 30%. These high rates were attributed to a highly sensitive cataract grading system (<a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a>). The authors also commented that the majority of patients in both arms of this study received glucocorticoid treatment and this is known to be associated with posterior subcapsular cataract formation. In one study (<a href="./references#CD007114-bbs2-0029" title="MarcocciC , BartalenaL , RocchiR , MarinoM , MenconiF , MorabitoE , et al. Long‐term safety of orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2003;88(8):3561‐6. ">Marcocci 2003</a>), the authors found an increase in cataract formation in patients that received radiotherapy via cobalt unit of 18% versus the collimation of radiotherapy with linear accelerator of 8%, which is the method used now. A separate retrospective study (<a href="./references#CD007114-bbs2-0043" title="SchaeferU , HesselmannS , MickeO , SchuellerP , BrunsF , PalmaC , et al. A long‐term follow‐up study after retro‐orbital irradiation for Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics2002;52(1):192‐7. ">Schaefer 2002</a>) of patients receiving bilateral orbital radiation for TED between 1963 and 1978 (n = 250, median follow‐up of 31 years) calculated a survival curve for the patients they were able to obtain follow‐up data on and compared this to an age‐adapted survival curve and a cancer‐specific survival curve. There was no significant difference between survival rates. </p> <p>Radiation retinopathy has also been described following radiotherapy treatment for TED. Of the 546 patients who received radiotherapy in these four studies, 36 developed retinal changes (6%) believed to be related to the radiotherapy (<a href="#CD007114-tbl-0010">Table 5</a>). The presence of co‐existing diabetes, hypertension, or both and a dose of 30 Gy were found to be associated with the development of retinopathy in two studies (<a href="./references#CD007114-bbs2-0030" title="MarquezSD , LumBL , McDougallIR , KatkuriS , LevinPS , MacManusM , et al. Long‐term results of irradiation for patients with progressive Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics2001;51(3):766‐74. ">Marquez 2001</a>; <a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a>) and implied in two (<a href="./references#CD007114-bbs2-0029" title="MarcocciC , BartalenaL , RocchiR , MarinoM , MenconiF , MorabitoE , et al. Long‐term safety of orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2003;88(8):3561‐6. ">Marcocci 2003</a>; <a href="./references#CD007114-bbs2-0041" title="RobertsonDM , BuettnerH , GormanCA , GarrityJA , FatourechiV , BahnRS , et al. Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy. Archives of Ophthalmology2003;121(5):652‐7. ">Robertson 2003</a>). Uveitis was considered a possible risk factor for vascular changes in one patient who developed de novo retinal changes (<a href="./references#CD007114-bbs2-0041" title="RobertsonDM , BuettnerH , GormanCA , GarrityJA , FatourechiV , BahnRS , et al. Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy. Archives of Ophthalmology2003;121(5):652‐7. ">Robertson 2003</a>). One study comparing those that had received radiotherapy to those that had not with a mean follow‐up of 11 years (SD three years) found the mortality levels to be similar in the two groups, at 27/159 (17%) in the irradiated group and 10/86 (12%) in the non‐irradiated group (P = 0.264) (<a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a>). One case report published in 1998 reported transitory visual loss following radiotherapy (<a href="./references#CD007114-bbs2-0036" title="NygaardB , SpechtL . Transitory blindness after retrobulbar irradiation of Graves ophthalmopathy. Lancet1998;351(9104):725‐6. ">Nygaard 1998</a>). </p> <div class="table" id="CD007114-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Retinopathy findings in long‐term follow‐up studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Important exclusions</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of retinopathy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of patients with retinal changes thought to be due to irradiation therapy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Important study findings</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0030" title="MarquezSD , LumBL , McDougallIR , KatkuriS , LevinPS , MacManusM , et al. Long‐term results of irradiation for patients with progressive Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics2001;51(3):766‐74. ">Marquez 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective review of notes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/197</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Logistic regression analysis found a radiation dose of 30 Gy to correlate with retinopathy (P = 0.02) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0023" title="GormanCA , GarrityJA , FatourechiV , BahnRS , PetersenIA , StaffordSL , et al. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology2002;109(11):2100‐7. ">Gorman 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetes mellitus excluded</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Photographs and FFA</p> <p>Only 37 patients had an FFA at baseline and 3 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> <p>Unclear if out of 42 patients irradiated or 37 with FFA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(<a href="./references#CD007114-bbs2-0041" title="RobertsonDM , BuettnerH , GormanCA , GarrityJA , FatourechiV , BahnRS , et al. Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy. Archives of Ophthalmology2003;121(5):652‐7. ">Robertson 2003</a>) </p> <p>Of the 3 patients who developed de novo changes, 2 had no retinal changes at baseline. Of these 1 had labile hypertension and borderline glucose levels and 1 had a history of uveitis, which were implied as risk factors for vascular changes </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0029" title="MarcocciC , BartalenaL , RocchiR , MarinoM , MenconiF , MorabitoE , et al. Long‐term safety of orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2003;88(8):3561‐6. ">Marcocci 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fundoscopy and FFA where necessary</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/204  </p> <p>(13 "minimal signs of hypertensive retinopathy"</p> <p>2 "possibly related to orbital irradiation")</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 in 7 (14%) had concurrent diabetes mellitus and hypertension</p> <p>1 of 31 (3%) had hypertension alone</p> <p>None of the 11 diabetic patients without hypertension or the 155 without diabetes or hypertension developed retinal changes </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed by retinal photographs</p> <p>(3 non‐irradiated not photographed)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27/103 irradiated group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetes mellitus had an RR of 21.0 (95% CI 3.0 to 179.0)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval <br/> FFA: Fundal fluorescein angiograms <br/> RR: risk ratio </p> </div> </div> <p>TED is a disease that significantly affects peoples' self‐esteem and mental state. As such, quality‐of‐life changes are an essential part of monitoring treatment. Only one study addressed this by using validated questionnaires, and did not have the power to comment on any changes due to low numbers (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). Consequently, conclusions regarding this are lacking in this review and will have to be addressed in future research. Similarly, the cost implications of orbital radiotherapy remain poorly assessed, with only one study considering this (<a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a>). As such, the existing data only reflects the cost in one country and also does not assess the long‐term cost implications. Further studies in other countries would give a better indication of the true cost of radiotherapy treatment in TED management. </p> </section> <section id="CD007114-sec2-0013"> <h3 class="title" id="CD007114-sec2-0013">Quality of the evidence</h3> <p>Overall 244 participants were randomised in the five studies analysed in this review. Each study was an RCT and therefore level one evidence. However, there were some sources of bias in the studies with unclear allocation concealment in three studies and with two of the studies only being single‐masked. Furthermore, only two studies attempted an ITT analysis. Combining the five studies into a meta‐analysis was not possible due to differences in the study designs and outcome measures used by the different authors. </p> </section> <section id="CD007114-sec2-0014"> <h3 class="title" id="CD007114-sec2-0014">Potential biases in the review process</h3> <p>Three review authors (RR, RL, CB) of this Cochrane review are investigators in an existing TED treatment trial, the Combined Immunosuppression and Radiotherapy in Thyroid Eye Disease (CIRTED) trial. This trial is investigating the use of azathioprine and radiotherapy as dual and triple therapy with glucocorticoids in moderate TED. The results of this trial remain concealed to all authors at present. The design of the trial may have influenced the outcome measures used in this review but these are internationally accepted and validated elsewhere. The trial committee members encourage further trials to use these validated outcomes of disease severity and activity and quality of life, to enable a meta‐analysis of results, and have published their protocol in an open‐access e‐journal (<a href="./references#CD007114-bbs2-0039" title="RajendramR , LeeRW , PottsMJ , RoseGE , JainR , OlverJM , et al. Protocol for the combined immunosuppression &amp; radiotherapy in thyroid eye disease (CIRTED) trial: a multi‐centre, double‐masked, factorial randomised controlled trial. Trials2008;9:6. ">Rajendram 2008</a>). </p> </section> <section id="CD007114-sec2-0015"> <h3 class="title" id="CD007114-sec2-0015">Agreements and disagreements with other studies or reviews</h3> <p>In general the literature regarding the use of radiotherapy in TED has remained inconclusive, with authors often sceptical and calling for further high‐level evidence (<a href="./references#CD007114-bbs2-0031" title="McNabAA . Does radiotherapy have a role in the management of thyroid orbitopathy?. British Journal of Ophthalmology2002;86(1):106‐7. ">McNab 2002</a>; <a href="./references#CD007114-bbs2-0034" title="MouritsMP . Does radiotherapy have a role in the management of thyroid orbitopathy ‐ View 2. British Journal of Ophthalmology2002;86(1):104‐6. ">Mourits 2002</a>). Some have suggested a benefit predominantly in extraocular muscle impairment (<a href="./references#CD007114-bbs2-0015" title="BradleyEA , GowerEW , BradleyDJ , MeyerDR , CahillKV , CusterPL , et al. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology. Ophthalmology2008;115(2):398‐409. ">Bradley 2008</a>; <a href="./references#CD007114-bbs2-0047" title="Stiebel‐KalishH , RobenshtokE , HasanreisogluM , EzrachiD , ShimonI , LeiboviciL . Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. Journal of Clinical Endocrinology and Metabolism2009;94(8):2708‐16. ">Stiebel‐Kalish 2009</a>) but not in proptosis, eyelid retraction and soft tissue inflammation. Our Cochrane review did not investigate the effect on these areas individually but the composite scores, which included these signs in conjunction with ocular motility, did show a beneficial effect of radiotherapy. </p> <p>Other reviews have agreed with our findings and report an overall favourable response to radiotherapy in comparison to sham radiotherapy and as combination therapy with glucocorticoids (<a href="./references#CD007114-bbs2-0014" title="BehbehaniR , SergottRC , SavinoPJ . Orbital radiotherapy for thyroid‐related orbitopathy. Current Opinion in Ophthalmology2004;15(6):479‐82. ">Behbehani 2004</a>; <a href="./references#CD007114-bbs2-0047" title="Stiebel‐KalishH , RobenshtokE , HasanreisogluM , EzrachiD , ShimonI , LeiboviciL . Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. Journal of Clinical Endocrinology and Metabolism2009;94(8):2708‐16. ">Stiebel‐Kalish 2009</a>; <a href="./references#CD007114-bbs2-0052" title="WeiRL , ChengJW , CaiJP . The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence. Ophthalmologica2008;222(1):27‐31. ">Wei 2008</a>). All of the reviews agreed with our findings that orbital radiotherapy is a relatively safe procedure when carried out correctly and at the widely used 20 Gy in 10 fractions. Despite no development of head or neck tumours in any long‐term study some authors have only recommended orbital radiotherapy in older patients due to the theoretical risk of carcinogenesis (<a href="./references#CD007114-bbs2-0014" title="BehbehaniR , SergottRC , SavinoPJ . Orbital radiotherapy for thyroid‐related orbitopathy. Current Opinion in Ophthalmology2004;15(6):479‐82. ">Behbehani 2004</a>). </p> <p>One of the prompts for conducting this Cochrane review was the publication of NICE guidelines on orbital radiotherapy in TED (<a href="./references#CD007114-bbs2-0035" title="National Institute for Health and Clinical Excellence. Retrobulbar irradiation for thyroid eye disease. www.nice.org.uk/ip257overview 2005 (accessed March 2012). ">NICE guidelines 2005</a>). NICE only recommend orbital radiotherapy if other treatments have failed or the patient has significant side effects to them. </p> <p>One of the four studies (<a href="./references#CD007114-bbs2-0007" title="GormanCA , GarrityJA , FatourechiV , Bahn , RS , PetersenIA , StaffordSL , et al. A prospective, randomized, double‐blind, placebo‐controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology2001;108(9):1523‐34. ">Gorman 2001</a>) NICE used for evidence showed no difference in outcome for radiotherapy versus sham radiotherapy. This is a study we excluded and one that has been criticised for its inclusion criteria (<a href="./references#CD007114-bbs2-0021" title="FeldonSE . Radiation therapy for Graves' ophthalmopathy: trick or treat?. Ophthalmology2001;108(9):1521‐2. ">Feldon 2001</a>). This Cochrane review, although limited, disagrees with the NICE recommendations as it found that radiotherapy was equivalent to glucocorticoid treatment alone and that combination with radiotherapy and glucocorticoids has increased efficacy and therefore orbital radiotherapy should not be reserved for second‐line treatment. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007114-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/urn:x-wiley:14651858:media:CD007114:CD007114-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_t/tCD007114-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Results from searching for studies for inclusion in the review." data-id="CD007114-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007114-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/urn:x-wiley:14651858:media:CD007114:CD007114-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_t/tCD007114-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Radiotherapy versus other intervention or sham radiotherapy, Outcome 1 Success ‐ composite outcomes score." data-id="CD007114-fig-00101" src="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Radiotherapy versus other intervention or sham radiotherapy, Outcome 1 Success ‐ composite outcomes score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007114-fig-00102"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of patients</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of patients needing operations</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mourits 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>radiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47 (total no of ops ‐ may be &gt; 1 per pt)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mourits 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>sham radiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 (total no of ops)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>radiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>steroid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>radiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>sham radiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Radiotherapy versus other intervention or sham radiotherapy, Outcome 2 Number of rehabilitative operations. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00102">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/urn:x-wiley:14651858:media:CD007114:CD007114-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_t/tCD007114-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Radiotherapy versus other intervention or sham radiotherapy, Outcome 3 NOSPECS improvement at 24 weeks." data-id="CD007114-fig-00103" src="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Radiotherapy versus other intervention or sham radiotherapy, Outcome 3 NOSPECS improvement at 24 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007114-fig-00104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/urn:x-wiley:14651858:media:CD007114:CD007114-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_t/tCD007114-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Radiotherapy versus other intervention or sham radiotherapy, Outcome 4 Clinical Activity Score ‐ change from baseline to 12 months." data-id="CD007114-fig-00104" src="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Radiotherapy versus other intervention or sham radiotherapy, Outcome 4 Clinical Activity Score ‐ change from baseline to 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007114-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/urn:x-wiley:14651858:media:CD007114:CD007114-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_t/tCD007114-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Radiotherapy plus steroids versus steroids, Outcome 1 Change in total eye score from baseline to 52 weeks." data-id="CD007114-fig-00201" src="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Radiotherapy plus steroids versus steroids, Outcome 1 Change in total eye score from baseline to 52 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007114-fig-00202"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Parameter</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Improvement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Static</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Worse</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total No. of Participants</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiotherapy &amp; steroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft Tissue</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Steroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft Tissue</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radiotherapy &amp; steroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ocular Motility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> <p>('normal eye motion' 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Steroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ocular Motility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>('normal eye motion' 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Radiotherapy plus steroids versus steroids, Outcome 2 NOSPECS change from baseline to 52 weeks. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00202">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/urn:x-wiley:14651858:media:CD007114:CD007114-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_t/tCD007114-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Radiotherapy plus steroids versus steroids, Outcome 3 Ophthalmopathy Index change from baseline to final visit." data-id="CD007114-fig-00203" src="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Radiotherapy plus steroids versus steroids, Outcome 3 Ophthalmopathy Index change from baseline to final visit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/media/CDSR/CD007114/image_n/nCD007114-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007114-fig-00301"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bartalena 1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>cushingoid features of 'most cases' with methyl pred alone or in combination</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bartalena 1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 depressive pscyhosis (methylprednisolone)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bartalena 1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 developed diabetic syndrome (methylprednisolone)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bartalena 1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 moderate increase in intraocular tension (methylprednisolone)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bartalena 1983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(No cataracts from radiotherapy in the 26 month follow up)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mourits 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 radiotherapy group had transient redness of skin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mourits 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 radiotherapy group had transient local hair loss</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mourits 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mourits 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mourits 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>steroids withdrawn prematurely in 1 of the steroid group due to recurrent Ramsay ‐ Hunt syndrome </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>steroids withdrawn early in 1 combination treatment group due to gastric discomfort</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 in each group developed moon face, weight gain, transient leucocytosis , hyperlipidaemia due to steroids </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2‐3 had hot flushes, gastro‐intestinal upset, hypertension, insomnia, eye or nose infections due to steroids. 1 developed acne due to steroids </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 in combined treatment group experienced mild exacerbation of peri‐orbital swelling &amp; transient redness of eyes, 3 had temporal hair loss </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean body weight increased from 71 (95% CI 67‐75)kg to 73(68‐78)kg in prednisolone group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 prednisolone group developed severe depression and 1 developed recurrent herpes zoster </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 prednisolone group developed hypertension; severe pyrosis developed in 5 prednisolone group and 2 radiotherapy group, 2 prednisolone patients developed hirsuitism, 3 prednisolone group developed behavioural changes, weight gain of greater than 2kg in 12 prednisolone group and 3 in radiotherapy group. 14 prednisolone group developed cushingoid face </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>no side effects in 3 prednisolone group and 13 radiotherapy group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No comment on side‐effects or adverse events</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Adverse events, Outcome 1 Side effects.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00301">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00401"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control mean(SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiotherapy mean (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Difference (95% CI)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>visual functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.5 (16.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2 (15.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.3 (‐11.5 to 6.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>appearance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5 (16.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7 (17.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 (‐8.4 to 10.7)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Change in quality of life between baseline and 12 months of treatment, Outcome 1 GO‐QoL (Graves Ophthalmopathy ‐ Quality of Life). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00401">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00402"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control mean (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiotherapy mean (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Difference(95% CI)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>physical functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.4 (19.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.3 (11.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1 (‐7.8 to 9.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>role functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0 (20.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7 (18.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.7 (‐6.1 to 15.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>social functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.2 (23.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.5 (23.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7 (‐11.7 to 15.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mental health</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.8 (17.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3 (19.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.1 (‐1.4 to 16.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>general health perceptions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.4 (16.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2 (16.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6 (‐5.5 to 12.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>bodily pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.0 (31.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.0 (32.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.04 (‐18.2 to 18.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>vitality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.4 (17.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3 (13.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7 (‐5.0‐12.4)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Change in quality of life between baseline and 12 months of treatment, Outcome 2 MOS‐24 (Medical Outcomes Study Short‐form General Health Survey). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00402">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00403"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control mean (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiotherapy mean (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Difference (95% CI)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>social interaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 (14.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5 (12.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 (‐5.3 to 10.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>household management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8 (19.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8 (12.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.1 (‐12.2 to 6.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>leisure pastimes &amp; recreation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.0 (22.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4 (16.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 (‐8.6 to 13.4)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Change in quality of life between baseline and 12 months of treatment, Outcome 3 SIP (Sickness Impact Profile). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00403">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00404"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control mean (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiotherapy mean (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Difference (95% CI)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2 (14.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 ( 14.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.0 (‐11.9 to 7.9)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Change in quality of life between baseline and 12 months of treatment, Outcome 4 Euro‐QoL. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00404">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00405"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>mean change in control group (SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>mean change in experimental group (SD)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+1.3 (0.9) (steroids)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+1.2 (0.8) (steroids &amp; radiotherapy)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+1(steroids)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>+0.8 (radiotherapy)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Change in quality of life between baseline and 12 months of treatment, Outcome 5 Subjective eye score. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00405">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007114-fig-00501"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>cost per patient in Euros</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>radiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5007</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prummel 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>sham‐irradiation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4465</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Health economic analysis, Outcome 1 Cost of treatment.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-fig-00501">Navigate to figure in review</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD007114-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Composite outcome score criteria</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Major criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Changes in the maximum eye movement in specified directions (measured in degrees, ≥ 8 degrees) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in Gorman diplopia score <br/> (none ‐ no double vision, intermittent ‐ double vision when tired or reported but not evident, inconstant ‐ double vision in certain directions of gaze, constant ‐ double vision in primary position or requiring a prism) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in visual acuity (Snellen acuity or converted Snellen acuity) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in soft tissue inflammation (predefined change in the appearance of the eyelids, conjunctiva, caruncle (which is the pink tissue in the medial corner of the eye), or a combination graded mild (1), moderate (2) or severe (3) according to a standardised colour atlas (<a href="./references#CD007114-bbs2-0017" title="DickinsonAJ , PerrosP . Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clinical Endocrinology2001;55(3):283‐303. ">Dickinson 2001</a>) or eyelid swelling alone (none, mild, moderate, severe) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change of palpebral/lid aperture (distance between upper and lower eyelid at the point midway across the pupil) of &gt; 2 mm </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Change in proptosis (protrusion of eyeball) of &gt; 2 mm </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in CAS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subjective improvement (predefined grading)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>†</sup>Used in more than 1 study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007114-bbs2-0002" title="MouritsMP , vanKempen‐HartveldML , GarciaMB , KoppeschaarHP , TickL , TerweeCB . Radiotherapy for Graves' orbitopathy: randomised placebo‐controlled study. Lancet2000;355(9124):1505‐9. ">Mourits 2000</a> </p> <p> <ul id="CD007114-lst1-0020"> <li> <p>Success = improvement in 1 or more major criterion or 2 minor criteria</p> </li> <li> <p>Failure = success definition not met</p> </li> </ul> </p> <p><a href="./references#CD007114-bbs2-0005" title="PrummelMF , TerweeCB , GerdingMN , BaldeschiL , MouritsMP , BlankL , et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2004;89(1):15‐20. ">Prummel 2004</a> </p> <p> <ul id="CD007114-lst1-0021"> <li> <p>Very good outcome = an improvement in at least 2 major criteria</p> </li> <li> <p>Good outcome = improvement of 1 major criterion</p> </li> <li> <p>Fair outcome = improvement of 2 minor criteria</p> </li> <li> <p>No change = no change in criteria or improvement of 1 minor criterion</p> </li> <li> <p>Worse = deterioration of at least 1 major criterion or 2 minor criteria</p> </li> </ul> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="1"> <div class="table-footnote"> <p>CAS: clinical activity score</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Composite outcome score criteria</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007114-tbl-0007"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Modified NOSPECS and total eye score (TES)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NOSPECS class</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>TES equivalent</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No signs or symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only signs (lid retraction, lid lag)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soft tissue involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: absent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: minimal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: marked</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proptosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: &lt; 20 mm</p> <p>(original score &lt; 23 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: 20 to 21 mm</p> <p>(original score 23 to 24 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: 21.5 to 24 mm</p> <p>(original score 25 to 27 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: &gt; 24 mm</p> <p>(original score &gt; 28 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eye muscle involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: absent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: limitation in extremes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: evident restriction of movement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: fixation of globes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Corneal involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 0: absent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade a: stippling/staining of cornea with fluorescein drops</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade b: ulceration of cornea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade c: clouding, necrosis, perforation of cornea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sight loss (Snellen acuity stated in American units)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class 0: better than 20/30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class a: 20/30 to 20/60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class b: 20/60 to 20/200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Class c: worse than 20/200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual class values added together to give total eye score</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Modified NOSPECS and total eye score (TES)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007114-tbl-0008"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Ophthalmopathy index</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Involvement</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Score</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Soft tissue involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mild</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>Proptosis (in mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="11" valign="top"> <p>Palpebral aperture (distance between upper and lower eyelids at mid‐pupil point) (in mm) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.95</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="10" valign="top"> <p>Difference between intraocular pressure looking straight ahead and that in upgaze</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Diplopia (double vision)</p> <p>(grades defined in composite score table)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intermittent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inconstant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Constant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Corneal involvement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Initial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcers</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clouding/perforation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Optic neuropathy (optic nerve damage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Abnormal visual evoked potential detected when vision better than 6/12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>(Snellen visual acuity expressed as fraction (e.g. 6/12 = 0.5))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 to 0.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1 to 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Ophthalmopathy index</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007114-tbl-0009"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Clinical activity score</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>(Each score 1 point)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain on eye movement in the last 4 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Painful, oppressive feeling on or behind eye globe in the last 4 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Redness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conjunctival redness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eyelid redness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Swelling</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chemosis (fluid under conjunctiva)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Swollen caruncle (pink tissue in medial corner of eye next to nose)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Eyelid oedema</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increasing proptosis of &gt; 2 mm during a period of 1 to 3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Impaired function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreasing visual acuity of &gt; 1 Snellen line (using a pinhole to obtain best corrected visual acuity) during a period of 1 to 3 months </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreasing eye movement of greater than or equal to 5 degrees during a period of 1 to 3 months </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Clinical activity score</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007114-tbl-0010"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Retinopathy findings in long‐term follow‐up studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Important exclusions</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of retinopathy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of patients with retinal changes thought to be due to irradiation therapy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Important study findings</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0030" title="MarquezSD , LumBL , McDougallIR , KatkuriS , LevinPS , MacManusM , et al. Long‐term results of irradiation for patients with progressive Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics2001;51(3):766‐74. ">Marquez 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective review of notes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/197</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Logistic regression analysis found a radiation dose of 30 Gy to correlate with retinopathy (P = 0.02) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0023" title="GormanCA , GarrityJA , FatourechiV , BahnRS , PetersenIA , StaffordSL , et al. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology2002;109(11):2100‐7. ">Gorman 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetes mellitus excluded</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Photographs and FFA</p> <p>Only 37 patients had an FFA at baseline and 3 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> <p>Unclear if out of 42 patients irradiated or 37 with FFA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(<a href="./references#CD007114-bbs2-0041" title="RobertsonDM , BuettnerH , GormanCA , GarrityJA , FatourechiV , BahnRS , et al. Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy. Archives of Ophthalmology2003;121(5):652‐7. ">Robertson 2003</a>) </p> <p>Of the 3 patients who developed de novo changes, 2 had no retinal changes at baseline. Of these 1 had labile hypertension and borderline glucose levels and 1 had a history of uveitis, which were implied as risk factors for vascular changes </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0029" title="MarcocciC , BartalenaL , RocchiR , MarinoM , MenconiF , MorabitoE , et al. Long‐term safety of orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism2003;88(8):3561‐6. ">Marcocci 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fundoscopy and FFA where necessary</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/204  </p> <p>(13 "minimal signs of hypertensive retinopathy"</p> <p>2 "possibly related to orbital irradiation")</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 in 7 (14%) had concurrent diabetes mellitus and hypertension</p> <p>1 of 31 (3%) had hypertension alone</p> <p>None of the 11 diabetic patients without hypertension or the 155 without diabetes or hypertension developed retinal changes </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007114-bbs2-0051" title="WakelkampIM , TanH , SaeedP , SchlingemannRO , VerbraakFD , BlankLE , et al. Orbital irradiation for Graves' ophthalmopathy: is it safe? A long‐term follow‐up. Ophthalmology2004;111(8):1557‐62. ">Wakelkamp 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessed by retinal photographs</p> <p>(3 non‐irradiated not photographed)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27/103 irradiated group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetes mellitus had an RR of 21.0 (95% CI 3.0 to 179.0)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval <br/> FFA: Fundal fluorescein angiograms <br/> RR: risk ratio </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Retinopathy findings in long‐term follow‐up studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/full#CD007114-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007114-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Radiotherapy versus other intervention or sham radiotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Success ‐ composite outcomes score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.92 [1.27, 2.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of rehabilitative operations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 NOSPECS improvement at 24 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical Activity Score ‐ change from baseline to 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Radiotherapy versus other intervention or sham radiotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007114-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Radiotherapy plus steroids versus steroids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in total eye score from baseline to 52 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 NOSPECS change from baseline to 52 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Ophthalmopathy Index change from baseline to final visit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Radiotherapy plus steroids versus steroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007114-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007114-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Change in quality of life between baseline and 12 months of treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 GO‐QoL (Graves Ophthalmopathy ‐ Quality of Life) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 MOS‐24 (Medical Outcomes Study Short‐form General Health Survey) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 SIP (Sickness Impact Profile) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Euro‐QoL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Subjective eye score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Change in quality of life between baseline and 12 months of treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007114-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Health economic analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Cost of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Health economic analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007114.pub2/references#CD007114-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007114.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007114-note-1205">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD007114-note-1204">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007114\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007114\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007114\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007114\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007114\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007114.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007114.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007114.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007114.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007114.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720114747"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007114.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720114751"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007114.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df90e88e69377',t:'MTc0MDcyMDExNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 